Quantum Biopharma (QNTM) Cash from Operations (2019 - 2026)
Quantum Biopharma (QNTM) reported Cash from Operations of 1668749.0 for Q1 2026, up 60.84% on a YoY basis from 1037551.85 in Q1 2025, and down 446.06% sequentially from 305598.0 in Q4 2025.
Quantum Biopharma (QNTM) Cash from Operations (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 7 years of Cash from Operations data on file, last reported at 1668749.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 60.84% year-over-year to 1668749.0; the trailing twelve-month figure through Mar 2026 stood at 5644918.0 (up 38.4% YoY), and the FY2025 full-year result was 8237012.0, down 19.79% from the prior year.
- Cash from Operations fell to 1668749.0 in Q1 2026, from 305598.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 9398050.0 in Q2 2022 to a low of 50340664.0 in Q4 2022.
- A 4-year average of 3470424.08 and a median of 1668749.0 in 2026 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations soared 63.85% in 2022 and tumbled 221.38% in 2025, its largest moves.
- Tracing QNTM's Cash from Operations over 4 years: stood at 50340664.0 in 2022, then soared by 98.34% to 835762.0 in 2024, then jumped by 63.43% to 305598.0 in 2025, then plunged by 446.06% to 1668749.0 in 2026.
- Business Quant data shows QNTM's Cash from Operations at 1668749.0 in Q1 2026, 305598.0 in Q4 2025, and 1721476.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.17 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | -1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.67 Mn |
| Mar 31, 2026 | -1.67 Mn |
| Dec 31, 2025 | -305,598.00 |
| Dec 31, 2025 | -305,598.00 |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -4.26 Mn |
| Mar 31, 2025 | -4.26 Mn |
| Dec 31, 2024 | -835,762.00 |
| Dec 31, 2024 | -835,762.00 |
| Sep 30, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | -606,482.00 |
| Jun 30, 2024 | -606,482.00 |
| Mar 31, 2024 | -1.97 Mn |
| Mar 31, 2024 | -1.97 Mn |
| Dec 31, 2022 | -50.34 Mn |
| Dec 31, 2022 | -50.34 Mn |